- Description
| Specificity Profile | More Information |
|
The specificity of Chikungunya Virus E1/E2 Monoclonal Antibody (CSB0135) was tested on the Membrane Proteome Array® and shown to be specific for Chikungunya Virus E1/E2. The Membrane Proteome Array® contains 6,000 different human membrane proteins, each expressed in unfixed human cells to ensure native conformation and post-translational modifications. The Membrane Proteome Array® represents the industry standard for determining the binding specificity of antibodies and other protein ligands. |
| Application | Conditions | Recommended Concentration |
| Flow Cytometry, Extracellular | Live, Unpermeabilized | 1 µg/ml |
|
HEK-293F cells transiently transfected with Chikungunya Virus E1/E2 were stained with Chikungunya Virus E1/E2 Monoclonal Antibody (CSB0135) (green) or isotype control antibody (gray), followed by AlexaFluor 647- conjugated anti-Mouse IgG secondary antibody. HEK-293F cells transiently transfected with an empty control vector were also stained with Chikungunya Virus E1/E2 Monoclonal Antibody (CSB0135) (blue). | |
CSB VeRSaMAbs:
We produce and validate all our monoclonal antibodies
in-house so that you can confidently choose the right antibody for your assay. All antibodies are
VALIDATED for common applications, RECOMBINANT for batch-to-batch consistency, and
SPECIFIC in binding to only your target.
| Target | Chikungunya Virus E1/E2 |
| Target Aliases | None |
| Isotype | Mouse IgG2a |
| Membrane Proteome Specificity | Monospecific for 6,000 membrane proteins tested |
| Species Reactivity | Virus |
| Fc Modifications | C-terminal Avitag, disabled Fc-gamma receptor binding |
| Source | Recombinant CHO expression; purified by Protein A chromatography |
| Formulation | Endotoxin Free PBS pH 7.4, sterile-filtered |
| Concentration | 1 mg/ml |
Stable for 12 months from date of receipt when stored at 4°C. Avoid repeated freeze-thaw cycles.
Chikungunya virus (CHIKV) is spread through bites from infected mosquitoes and can cause fever, joint pain and swelling, headache, muscle pain, or a rash (https://www.cdc.gov/chikungunya/index.html). This antibody has cross-reactivity with O’nyong’nyong virus (ONNV).
